Schizophrenia Clinical Trial
Official title:
The Efficacy of Neural Stimulation in Individuals With Schizophrenia
Verified date | March 2024 |
Source | The University of Texas at Dallas |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to understand the relationship between psychotic symptoms and social functioning in individuals with schizophrenia spectrum disorders. Our goal is to determine whether stimulating the brain using transcranial Direct Current Stimulation (tDCS) can improve symptoms and daily functioning.
Status | Active, not recruiting |
Enrollment | 50 |
Est. completion date | May 2025 |
Est. primary completion date | August 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 64 Years |
Eligibility | Inclusion Criteria: - Age = 18-64 - Diagnosed with schizophrenia or schizoaffective disorder - Having current (in the past week) or recent (in the past month) paranoia Exclusion Criteria: - Presence or history of a pervasive developmental disorder or mental retardation as defined by IQ < 70 - Presence or history of neurological or medical disorders that contraindicate neural stimulation (e.g. presence or history of epilepsy, seizures, etc.) - Demonstrating sensory limitations, including uncorrectable visual or hearing impairments that interfere with assessment - History of electroconvulsive therapy - Lack of proficiency in English - Substance use disorder not in remission in the past 6 months - Any implanted devices such as pace maker, neurostimulator - Pregnancy |
Country | Name | City | State |
---|---|---|---|
United States | The Unversity of Texas at Dallas | Richardson | Texas |
Lead Sponsor | Collaborator |
---|---|
The University of Texas at Dallas |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Paranoid Ideation for Active vs. Sham Stimulation | Paranoid ideation will be measured by the State Social Paranoia Scale (SSPS). Participants will indicate how much they agree with each of 20 statements (e.g., "Someone was hostile towards me", "Someone was trying to isolate me") using a 5-point Likert scale (1 = do not agree, 5 = totally agree). Scores range from 20-100, and higher scores represent higher state paranoid ideation. | The assessment will be completed 30 minutes after completion of the active/sham stimulation | |
Primary | Paranoid Ideation for Active vs. Sham Stimulation | Paranoid ideation will be measured by the Hostility Scale of the Personality Inventory for DSM-5 (PID-5-HS). PID-5-HS contains 10 self-report items (e.g., "I snap at people when they do little things that irritate me") assessing pathological hostility on a 4-point scale (0 = very false or often false, 3 = very true or often true), with higher total scores indicating more hostility (range = 0-30). | The assessment will be completed 30 minutes after completion of the active/sham stimulation | |
Primary | Paranoid Ideation for Active vs. Sham Stimulation | Paranoid ideation will be measured by the Ambiguous Intentions Hostility Questionnaire (AIHQ). Five ambiguous scenarios will be presented to participants, and they will be asked to give reasons why each situation happened, indicate how much they think that people did this to them on purpose, how angry they are, how much they will blame others, and what they will do about it. Responses will be recorded verbatim or based on 6-point (if the behavior is on purpose) and 5-point (how angry they are, how much they will blame others) Likert scales. For the open-ended questions, hostility and aggression biases will be rated by three independent, trained raters using a 5-point Likert scale (1 = not hostile/aggressive at all, 5 = very hostile/aggressive). Inter-rater reliability will be computed by ICC among all the raters, with ICC > .80 being acceptable. | The assessment will be completed 30 minutes after completion of the active/sham stimulation | |
Primary | Paranoid Ideation for Active vs. Sham Stimulation | Paranoid ideation will be measured by the Scrambled-sentences task (SST) | The assessment will be completed 30 minutes after completion of the active/sham stimulation | |
Primary | Paranoid Ideation for Active vs. Sham Stimulation | Paranoid ideation will be measured by the Trustworthiness Task | The assessment will be completed 30 minutes after completion of the active/sham stimulation | |
Primary | Paranoid Ideation for Active vs. Sham Stimulation | Paranoid ideation will be measured by EMA (i.e., questions about feelings of paranoia in daily life). | Change in daily paranoia feelings will be assessed from the pre-stimulation EMA period (7 days before the stimulation visit) to the post-stimulation EMA period (7 days after the stimulation visit) | |
Primary | Social functioning for Active vs. Sham Stimulation | Social functioning will be measured by the Birchwood Social Functioning Scale (SFS). This scale measures social adjustment based on self-reports (4- or 5-point scales), with higher total scores indicating better social functioning (range = 0-223). | The assessment will be completed 30 minutes after completion of the active/sham stimulation | |
Primary | Social functioning for Active vs. Sham Stimulation | Social functioning will be measured by EMA (i.e., questions about daily interactions with others) | Change in daily interactions will be assessed from the pre-stimulation EMA period (7 days before the stimulation visit) to the post-stimulation EMA period (7 days after the stimulation visit) | |
Primary | Social functioning for Active vs. Sham Stimulation | Social functioning will be measured by EMA (i.e., questions about daily experience in social interactions). | Change in daily experience in social interactions will be assessed from the pre-stimulation EMA period (7 days before the stimulation visit) to the post-stimulation EMA period (7 days after the stimulation visit) | |
Primary | Social functioning for Active vs. Sham Stimulation | Social functioning will be measured by EMA (i.e., questions about daily expectations of social interactions). | Change in daily expectations of social interactions will be assessed from the pre-stimulation EMA period (7 days before the stimulation visit) to the post-stimulation EMA period (7 days after the stimulation visit) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |